Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC)

van der Heijden, M. S. and Powles, T. B. and Galsky, M. D. and Catto, J. W. F. and Meeks, J. and Zukov, R. and Izumi, K. and Huang, K. H. and Bekir Hacioglu, M. and Hussain, S. A. and Necchi, A. and Dumez, H. and Schnabel, Marco J. and Bigot, P. and Estay, A. C. and Lui, A. G. A. and Cernadas, C. and Bigos, K. and Hois, S. and Nishiyama, H. (2025) Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC). ANNALS OF ONCOLOGY, 36 (S2). S1483. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 15 Oct 2026 05:49
Last Modified: 15 Oct 2026 05:49
URI: https://pred.uni-regensburg.de/id/eprint/67819

Actions (login required)

View Item View Item